Study Summary
This trial compares single-fraction SBRT to standard radiation therapy in treating metastatic cancer. SBRT uses special equipment to deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue.
- Metastatic Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: Up to 12 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Arm II (SBRT)
1 of 2
Arm I (palliative RT)
1 of 2
Experimental Treatment
1500 Total Participants · 2 Treatment Groups
Primary Treatment: Quality-of-Life Assessment · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is Quality-of-Life Assessment a reliable predictor of patient safety and health outcomes?
"Since this is a phase 2 trial, there is some evidence of safety but not efficacy. Therefore, our team scores Quality-of-Life Assessment as a 2." - Anonymous Online Contributor
Is there still room for new patients in this clinical trial?
"This research, which was initially published on November 18th 2019, is still recruiting patients according to information found on clinicaltrials.gov. The most recent update was made on May 2nd, 2022." - Anonymous Online Contributor